$TherapeuticsMD (TXMD.US)$Overall revenue has continued to g...
$TherapeuticsMD(TXMD.US$Overall revenue has continued to grow over the past 5 years, but in 2021 it was almost zero. Operating profit continued to be lost in the previous 4 years, and the loss was reversed to reach $11 million in 2022. Net profit reached 112 million in 2022 after 4 years of continuous losses.
The profit table shows that the vast majority of profit in 2022 came from the cessation of operating profit of 111 million, which is unsustainable. Continued operating profit is only 1.07 million. Based on the current market value of 44.33 million, the price-earnings ratio has reached 41. It is possible to observe the situation for a few more quarters before making a judgment.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
